清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Cancer trends and burden in India

癌症 医学 斯科普斯 入射(几何) 人口 人口学 疾病负担 疾病 癌症登记处 疾病负担 癌症发病率 梅德林 内科学 环境卫生 生物 物理 光学 社会学 生物化学
作者
K Chandramohan,Boben Thomas
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:19 (12): e663-e663 被引量:18
标识
DOI:10.1016/s1470-2045(18)30839-8
摘要

In October, 2018, Lalit Dandona and colleagues 1 India State-Level Disease Burden Initiative Cancer CollaboratorsThe burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol. 2018; 19: 1289-1306 Summary Full Text Full Text PDF PubMed Scopus (181) Google Scholar published the findings of their Global Burden of Disease (GBD) Study of the burden and incidence of cancers in India, in The Lancet Oncology. The previous month, GLOBOCAN, a trusted source of global cancer statistics, published its report of cancer incidence in India, using 2018 estimates. 2 Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; (published online Sept 12.)DOI:10.3322/caac.21492 Crossref PubMed Scopus (50356) Google Scholar The number of cancers diagnosed in India in 2012, according to GLOBOCAN estimates, was 1 157 294, versus 1 069 000 in the GDB India study. The GBD study, which reported on 28 types of cancer, used data from 42 population-based cancer registries in India, whereas GLOBOCAN 2018, which reported on 36 types of cancer, was based on Cancer incidence in five continents volume XI and used data from 16 Indian cancer registries. Both studies used the data available in their selected population-based cancer registries from 2008 to 2012 to calculate estimates of cancer incidence between 2016 and 2018. Unfortunately, the data from different population-based cancer registries vary in accuracy, 3 Parkin DM The evolution of the population-based cancer registry. Nat Rev Cancer. 2006; 6: 603-612 Crossref PubMed Scopus (286) Google Scholar which might be the reason why GLOBOCAN 2018 only retrieved data from the 16 cancer registries they deemed were of better quality to estimate incidence. Similarly, the age-standardised incidence of breast cancer in India, in 2018, was reported to be 40·7 per 100 000 people in the GBD study compared with 24·7 per 100 000 people according to GLOBOCAN 2018 estimates. This substantial difference in the age-standardised incidence of breast cancer questions the credibility of the GBD study. Similarly, according to the GBD study, the highest estimate of crude cancer incidence in India was in the state of Kerala (135·3 per 100 000 people). But this estimate seems far from real. The data from Kerala were retrieved from the population-based cancer registry maintained by the Regional Cancer Centre in Trivandrum. This registry has better manpower, infrastructure, and resources to capture accurate cancer data from the region than registries in the rest of India. The average life expectancy in Kerala is 7 years higher than that of the rest of India (mean 67·9 years vs 74·9 years), 4 National Institution for Transforming IndiaLife expectancy. http://niti.gov.in/content/life-expectancyDate accessed: November 1, 2018 Google Scholar which might be due to a better sociodemographic index and health-care delivery system in the region. Therefore, the reported higher crude cancer incidence in Kerala compared with the rest of India might be due to the efficiency of the regional population-based cancer registry to record cancer cases and the longer life expectancy of the population in this region. Cancer trends and burden in IndiaThe Global Burden of Disease study1 published in The Lancet Oncology highlights the need to understand the reasons behind the changing trends in different cancer burdens in India between 1990 and 2016. In India, economic liberalisation started in the early 1990s and was followed by rapid industrialisation; after liberalisation, foreign direct investments grew more in the polluting sectors than in the less polluting sectors. So, environmental pollution that started in the early and late 1990s will show its effect now, as far as cancer is concerned, and this might partly explain the changing trends of cancer. Full-Text PDF Cancer trends and burden in India – Authors' responseRegarding the differences between Global Burden of Disease (GBD) and GLOBOCAN estimates raised by Chandramohan K and Boben Thomas, GBD uses all available relevant sources of data for cancer incidence estimates, including population-based cancer registries and mortality data from India's nationwide Sample Registration System and the Medically Certified Cause of Death data, whereas GLOBOCAN incidence estimates rely only on data from population-based cancer registries, which cover less than 10% of India's population. Full-Text PDF Cancer trends and burden in IndiaThe Global Burden of Disease Study on cancers, published in The Lancet Oncology, provides excellent data about variations in cancer incidence across the states of India.1 However, I wish to express two concerns about statements regarding breast and colorectal cancer screening. Full-Text PDF Cancer trends and burden in IndiaCancers put an enormous burden on society. A Global Burden of Disease (GBD) study published in The Lancet Oncology1 reported that of the northeastern states (with a population of 45 million people), Mizoram, Meghalaya, Arunachal Pradesh, and Assam have the highest burden of cancer in terms of age-standardised mortality and incidence, and low survival rates. The findings of this study also correlate with the findings of the National Cancer Registry Programme of India, which shows that, in men, Aizawl district in Mizoram state has the highest incidence of all cancers (270 per 100 000 people) followed by Papumpare district (230 per 100 000 people) in Arunachal Pradesh; for women, the highest incidence of cancer is in Papumpare district (249 per 100 000 people), followed by Aizawl district (207 per 100 000). Full-Text PDF The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016The substantial heterogeneity in the state-level incidence rate and health loss trends of the different types of cancer in India over this 26-year period should be taken into account to strengthen infrastructure and human resources for cancer prevention and control at both the national and state levels. These efforts should focus on the ten cancers contributing the highest DALYs in India, including cancers of the stomach, lung, pharynx other than nasopharynx, colon and rectum, leukaemia, oesophageal, and brain and nervous system, in addition to breast, lip and oral cavity, and cervical cancer, which are currently the focus of screening and early detection programmes. Full-Text PDF Open Access

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
忧伤的傲芙完成签到,获得积分10
4秒前
小元元完成签到 ,获得积分10
5秒前
微笑的巧蕊完成签到 ,获得积分10
8秒前
躺平写文章完成签到,获得积分10
12秒前
专注湘完成签到,获得积分10
12秒前
Cosmosurfer完成签到,获得积分0
28秒前
眯眯眼的安雁完成签到 ,获得积分10
40秒前
害羞雪珊完成签到,获得积分10
42秒前
温柔樱桃完成签到 ,获得积分10
42秒前
满意的伊完成签到,获得积分10
43秒前
魔幻的松思完成签到,获得积分10
45秒前
飞哥与小佛完成签到,获得积分10
47秒前
51秒前
Julian完成签到,获得积分0
54秒前
从容美女发布了新的文献求助10
57秒前
seeyou14发布了新的文献求助20
59秒前
健忘初露完成签到,获得积分10
1分钟前
YANGMJ完成签到,获得积分10
1分钟前
汉堡包的应助被科研通管家采纳,获得50
1分钟前
n01W97的应助被科研通管家采纳,获得20
1分钟前
Orange的应助被科研通管家采纳,获得10
1分钟前
yhr完成签到,获得积分10
1分钟前
闪闪的访烟完成签到,获得积分10
1分钟前
yiyi完成签到 ,获得积分10
1分钟前
aRuuuu完成签到 ,获得积分10
1分钟前
兴奋雅香完成签到,获得积分10
2分钟前
小马甲的应助被amiee采纳,获得10
2分钟前
开放的乐驹完成签到 ,获得积分10
2分钟前
俊秀的箴完成签到,获得积分10
2分钟前
2分钟前
jindou完成签到,获得积分10
2分钟前
amiee发布了新的文献求助10
2分钟前
俊逸代男完成签到,获得积分10
2分钟前
阔达的芹菜完成签到,获得积分10
2分钟前
情怀的应助被amiee采纳,获得10
2分钟前
Akim的应助被俊逸代男采纳,获得10
2分钟前
Qinzhiyuan1990完成签到 ,获得积分10
2分钟前
兴奋巧凡完成签到,获得积分10
2分钟前
阿浮完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185483
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783085
什么是DOI,文献DOI怎么找? 3434576
关于科研通互助平台的介绍 2558929
邀请新用户注册赠送积分活动 2481346